Market Survey on Arteriovenous Fistula Treatment Market Covering Sales Outlook, Up-to-date Key Trends, Market Size and Forecast, Per Capita Expenditure, Company Share, Brand Share, Regulations, Reimbursement Scenario, Epidemiology, Procedure Numbers, and Pipeline Assessment
An In-depth Market Insights of Arteriovenous Fistula Treatment Market including Arteriovenous Fistulas, Dural, Peripheral, and Pial or Cerebral Covering 30+ Countries like United States, United Kingdom, Germany, France, Norway, Sweden, Saudi Arabia, United Arab Emirates, Japan, Korea, Australia, New Zealand, and Others
Arteriovenous Fistula Treatment Market Outlook (2023 to 2033)
The global arteriovenous fistula treatment market is projected to amass revenue of about US$ 1,356.5 million by 2033. The overall market value is expected to be worth US$ 765.8 million in 2023. The worldwide adoption of arteriovenous fistula treatment is projected to advance at a CAGR of 5.9% during this forecast period.
In the near future, the market for arteriovenous fistulas is also likely to be boosted by medicines in the clinical pipeline and supportive government efforts. However, risks associated with arteriovenous fistula needles are likely to create a dent in the market share growth.
The clearance given by FDI of Vascugel, an investigational novel medication for the treatment of failed hemodialysis access grafts, for a pivotal phase III trial by Pervasis Therapeutics, Inc. is one such instance. Therefore, these government initiatives and approvals are expected to open up a wide array of arteriovenous fistula treatment market opportunities and a sound foundation for the expansion of this market.
Due to ongoing efforts by leading companies to provide cutting-edge therapies for the treatment of arteriovenous fistula, the market size is expanding rapidly on a global scale. For instance, in April 2013, Shire released the results of a phase II research to determine the effectiveness and safety of SRM003 (Vascugel) in patients with end-stage renal disease and an arteriovenous fistula.
As per the market report by FMI, the arteriovenous fistula treatment methods are in research to come up in the market, and the same is also likely to sway the market.
For doctors to pinpoint the precise size and location of damaged blood arteries, imaging techniques like computed tomography (CT) and magnetic resonance imaging (MRI) are helpful, catering to the arteriovenous fistula treatment market growth. To effectively treat arteriovenous fistulas, additional surgical procedures are carried out. To reduce blood clotting in the affected locations, as fistulas in the brain and eye are tough to cure, injectable treatment is employed in this instance.
Report Attributes or Data Points
Details
Global Arteriovenous Fistula Treatment Market Valuation in 2022
US$ 731.6 million
Estimated Global Market Share in 2023
US$ 765.8 million
Forecasted Global Market Size by 2033
US$ 1,356.5 million
Projected Global Market Growth Rate from 2023 to 2033
5.9% CAGR
Historical Market Growth Rate from 2018 to 2022
3.8% CAGR
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
What Factors Are Spearheading the Arteriovenous Fistula Treatment Market?
The adoption of arteriovenous fistula treatment is growing over the forecast period as the players are coming up with new treatment methods, such as photodynamic therapy, antiangiogenic therapy, and another method of sclerotherapy.
The effective treatment method for a complete cure in an easy way is still under development process, which initiates the players to come up with innovations for the treatment, shaping the market trends.
On the flip side, the lack of awareness regarding arteriovenous fistula treatment hinders the demand for arteriovenous fistula treatment worldwide.
The market for arteriovenous fistula treatment bears a huge potential as the treatment methods are limited, and the population effect is high, directly influencing the market growth.
Regional Market Comparison
Global Market Share in Percentage
North America
37.2%
Europe
27.4%
Which Region is Expected to be at the Forefront of the Arteriovenous Fistula Treatment Market?
Due to the successful measures taken by the US government to create novel therapies for the arteriovenous fistula problem, North America controls the majority of the global market share, accounting for 37.2% in 2022.
To this, North America has a huge potential as leading pharmaceutical players are placed in that region, positively impacting the overall market over the forecast period.
Find your sweet spots for generating winning opportunities in this market.
What are the Growth Prospects for the European Arteriovenous Fistula Treatment Market?
The second-leading market for arteriovenous fistulas is anticipated to be in Europe, with a share of 27.4% in 2022. Arteriovenous fistula incidence is rising, and there is a strong need for medicines to treat them in Europe, which is mostly responsible for the market's expansion in the region during the forecast period.
Europe's market growth has been soaring, attributed to rising awareness of the treatment in the region.
Regional Markets
CAGR (2023 to 2033)
United Kingdom
5.4%
China
9.4%
India
7.7%
Australia
6.8%
How is the Start-up Ecosystem in the Arteriovenous Fistula Treatment Market?
Numerous start-ups have been emerging in various industries, including the arteriovenous fistula treatment solutions, and are bringing about emerging trends in the market.
Example:
To raise the marketing of its FDA-cleared implant that enables patients with end-stage renal disease (ESRD) to more easily access their vascular system for hemodialysis, Vital Access, a start-up, obtained a US$10 million credit line from Deerfield Management.
The FDA approved the Salt Lake City, Utah-based company's device in 2013.
In 96% of patients with fistulas confirmed to be uncalculatable in the SAVE research, a prospective, pivotal clinical trial in the United States, it was demonstrated that VWING provided dependable fistula access.
In comparison to published rates, its usage in the study was linked to a significantly decreased incidence of access site and systemic infection over the long term.
Category
By Type
Top Segment
Arteriovenous Fistulas
Market Share in Percentage
29.8%
Category
By Treatment
Top Segment
Transcatheter Embolization
Market Share in Percentage
42.7%
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need and save 40%!
What is the Competition Landscape in the Arteriovenous Fistula Treatment Market?
Players in the market are engaging in various organic and inorganic strategies, including mergers & acquisitions, partnerships, product launches, and collaborations, thereby augmenting their market share.
Recent development:
The WavelinQTM 4F EndoAVF System, BD's next-generation technology, provides additional places to establish an AV fistula while leaving open the possibility of creating AV fistulas through regular surgical procedures in the future.
The surgical scar frequently left behind after creating an AV fistula during open surgery is removed with the endovascular technique, carried out through two tiny punctures or incisions.
Patients concerned about AV fistula formation with standard surgery may opt for an endoAVF.
Key Players
Becton Dickinson & Company - They are an American multinational medical technology company that manufactures and sells medical devices, instrument systems, and reagents. BD also provides consulting and analytics services in certain geographies.
Medtronic - They are the global leader in medical technology, services, and solutions. They collaborate with others to take on healthcare's greatest challenges.
B. Braun Melsungen Ag - They develop effective solutions and guiding standards for the healthcare system in a constructive dialogue with our customers and partners.
Cook Medical - They are an American privately held company based in Bloomington, Indiana, and primarily involved in the manufacturing of medical devices. They were ranked #324 in Forbes' 2008 America's Largest Private Companies.
Teleflex Incorporated - They are an American provider of specialty medical devices for a range of procedures in critical care and surgery. Teleflex has annual revenues of US$ 2.4 Billion, operations in 40 countries, and more than 12,000 employees.
Other Market Participants:
Fresenius Medical Care AG & Co. KGaA
NxStage Medical Inc.
Poly Medicure Limited.
Report Scope
Report Attributes
Details
Growth Rate
CAGR of 5.9% from 2023 to 2033
Base Year for Estimation
2022
Historical Data
2018 to 2022
Forecast Period
2023 to 2033
Quantitative Units
Revenue in US$ million and CAGR from 2023 to 2033
Report Coverage
Revenue Forecast, Volume Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends, and Pricing Analysis
Segments Covered
Type
Treatment Type
Region
Regions Covered
North America
Latin America
Asia Pacific
The Middle East and Africa
Europe
Key Countries Profiled
Canada
Brazil
Argentina
Germany
United Kingdom
France
Spain
Italy
Nordics
BENELUX
Australia & New Zealand
China
India
ASIAN
GCC Countries
South Africa
Key Companies Profiled
Becton Dickinson & Company
Medtronic
B. Braun Melsungen Ag
Cook Medical
Teleflex Incorporated
Fresenius Medical Care AG & Co. KGaA
NxStage Medical Inc.
Poly Medicure Limited.
Customization
Available Upon Request
Key Segments Profiled in the Arteriovenous Fistula Treatment Industry Survey Report
By Type:
Arteriovenous Fistulas
Dural
Peripheral
Pial or Cerebral
Other Fistula Types
By Treatment Type:
Drugs
Transcatheter Embolization
Ultrasound-guided Compression
Surgery
By Region:
North America
Latin America
Asia Pacific
The Middle East and Africa
Europe
Frequently Asked Questions
How big is the Arteriovenous Fistula Treatment market by 2033?
The projected revenue of the market by 2033 is US$ 1,356.5 million.
What is the Arteriovenous Fistula Treatment Market CAGR for 2033?
The market CAGR for 2033 is projected to be 5.9%.
Which are the Top Three Countries Leading the Market?
North America, Europe, and Asia-Pacific are the leading market.
Which region holds a significant share of the Arteriovenous Fistula Treatment market?
North America holds the largest market share.
Why is the North American market growing remarkably fast?
North America is growing fast due to the rising prevalence of chronic diseases.
Table of Content
1. Executive Summary
1.1. Global Market Outlook
1.2. Demand-side Trends
1.3. Supply-side Trends
1.4. Technology Roadmap Analysis
1.5. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Market Background
3.1. Market Dynamics
3.1.1. Drivers
3.1.2. Restraints
3.1.3. Opportunity
3.1.4. Trends
3.2. Scenario Forecast
3.2.1. Demand in Optimistic Scenario
3.2.2. Demand in Likely Scenario
3.2.3. Demand in Conservative Scenario
3.3. Opportunity Map Analysis
3.4. Investment Feasibility Matrix
3.5. PESTLE and Porter’s Analysis
3.6. Regulatory Landscape
3.6.1. By Key Regions
3.6.2. By Key Countries
3.7. Regional Parent Market Outlook
4. Global Market Analysis 2018 to 2022 and Forecast, 2023 to 2033
4.1. Historical Market Size Value (US$ Million) Analysis, 2018 to 2022
4.2. Current and Future Market Size Value (US$ Million) Projections, 2023 to 2033
4.2.1. Y-o-Y Growth Trend Analysis
4.2.2. Absolute $ Opportunity Analysis
5. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Type
5.1. Introduction / Key Findings
5.2. Historical Market Size Value (US$ Million) Analysis By Type, 2018 to 2022
5.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Type, 2023 to 2033
5.3.1. Arteriovenous Fistulas
5.3.2. Dural
5.3.3. Peripheral
5.3.4. Pial or Cerebral
5.3.5. Others
5.4. Y-o-Y Growth Trend Analysis By Type, 2018 to 2022
5.5. Absolute $ Opportunity Analysis By Type, 2023 to 2033
6. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Treatment Type
6.1. Introduction / Key Findings
6.2. Historical Market Size Value (US$ Million) Analysis By Treatment Type, 2018 to 2022
6.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Treatment Type, 2023 to 2033
6.3.1. Drugs
6.3.2. Transcatheter Embolization
6.3.3. Ultrasound-guided Compression
6.3.4. Surgery
6.4. Y-o-Y Growth Trend Analysis By Treatment Type, 2018 to 2022
6.5. Absolute $ Opportunity Analysis By Treatment Type, 2023 to 2033
7. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region
7.1. Introduction
7.2. Historical Market Size Value (US$ Million) Analysis By Region, 2018 to 2022
7.3. Current Market Size Value (US$ Million) Analysis and Forecast By Region, 2023 to 2033
7.3.1. North America
7.3.2. Latin America
7.3.3. Western Europe
7.3.4. Eastern Europe
7.3.5. South Asia and Pacific
7.3.6. East Asia
7.3.7. Middle East and Africa
7.4. Market Attractiveness Analysis By Region
8. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
8.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
8.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
8.2.1. By Country
8.2.1.1. USA.
8.2.1.2. Canada
8.2.2. By Type
8.2.3. By Treatment Type
8.3. Market Attractiveness Analysis
8.3.1. By Country
8.3.2. By Type
8.3.3. By Treatment Type
8.4. Key Takeaways
9. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
9.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
9.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
9.2.1. By Country
9.2.1.1. Brazil
9.2.1.2. Mexico
9.2.1.3. Rest of Latin America
9.2.2. By Type
9.2.3. By Treatment Type
9.3. Market Attractiveness Analysis
9.3.1. By Country
9.3.2. By Type
9.3.3. By Treatment Type
9.4. Key Takeaways
10. Western Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
10.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
10.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
10.2.1. By Country
10.2.1.1. Germany
10.2.1.2. United Kingdom.
10.2.1.3. France
10.2.1.4. Spain
10.2.1.5. Italy
10.2.1.6. Rest of Western Europe
10.2.2. By Type
10.2.3. By Treatment Type
10.3. Market Attractiveness Analysis
10.3.1. By Country
10.3.2. By Type
10.3.3. By Treatment Type
10.4. Key Takeaways
11. Eastern Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
11.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
11.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
11.2.1. By Country
11.2.1.1. Poland
11.2.1.2. Russia
11.2.1.3. Czech Republic
11.2.1.4. Romania
11.2.1.5. Rest of Eastern Europe
11.2.2. By Type
11.2.3. By Treatment Type
11.3. Market Attractiveness Analysis
11.3.1. By Country
11.3.2. By Type
11.3.3. By Treatment Type
11.4. Key Takeaways
12. South Asia and Pacific Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
12.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
12.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
12.2.1. By Country
12.2.1.1. India
12.2.1.2. Bangladesh
12.2.1.3. Australia
12.2.1.4. New Zealand
12.2.1.5. Rest of South Asia and Pacific
12.2.2. By Type
12.2.3. By Treatment Type
12.3. Market Attractiveness Analysis
12.3.1. By Country
12.3.2. By Type
12.3.3. By Treatment Type
12.4. Key Takeaways
13. East Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
13.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
13.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
13.2.1. By Country
13.2.1.1. China
13.2.1.2. Japan
13.2.1.3. South Korea
13.2.2. By Type
13.2.3. By Treatment Type
13.3. Market Attractiveness Analysis
13.3.1. By Country
13.3.2. By Type
13.3.3. By Treatment Type
13.4. Key Takeaways
14. Middle East and Africa Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
14.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
14.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
14.2.1. By Country
14.2.1.1. GCC Countries
14.2.1.2. South Africa
14.2.1.3. Israel
14.2.1.4. Rest of MEA
14.2.2. By Type
14.2.3. By Treatment Type
14.3. Market Attractiveness Analysis
14.3.1. By Country
14.3.2. By Type
14.3.3. By Treatment Type
14.4. Key Takeaways
15. Key Countries Market Analysis
15.1. USA.
15.1.1. Pricing Analysis
15.1.2. Market Share Analysis, 2022
15.1.2.1. By Type
15.1.2.2. By Treatment Type
15.2. Canada
15.2.1. Pricing Analysis
15.2.2. Market Share Analysis, 2022
15.2.2.1. By Type
15.2.2.2. By Treatment Type
15.3. Brazil
15.3.1. Pricing Analysis
15.3.2. Market Share Analysis, 2022
15.3.2.1. By Type
15.3.2.2. By Treatment Type
15.4. Mexico
15.4.1. Pricing Analysis
15.4.2. Market Share Analysis, 2022
15.4.2.1. By Type
15.4.2.2. By Treatment Type
15.5. Germany
15.5.1. Pricing Analysis
15.5.2. Market Share Analysis, 2022
15.5.2.1. By Type
15.5.2.2. By Treatment Type
15.6. United Kingdom.
15.6.1. Pricing Analysis
15.6.2. Market Share Analysis, 2022
15.6.2.1. By Type
15.6.2.2. By Treatment Type
15.7. France
15.7.1. Pricing Analysis
15.7.2. Market Share Analysis, 2022
15.7.2.1. By Type
15.7.2.2. By Treatment Type
15.8. Spain
15.8.1. Pricing Analysis
15.8.2. Market Share Analysis, 2022
15.8.2.1. By Type
15.8.2.2. By Treatment Type
15.9. Italy
15.9.1. Pricing Analysis
15.9.2. Market Share Analysis, 2022
15.9.2.1. By Type
15.9.2.2. By Treatment Type
15.10. Poland
15.10.1. Pricing Analysis
15.10.2. Market Share Analysis, 2022
15.10.2.1. By Type
15.10.2.2. By Treatment Type
15.11. Russia
15.11.1. Pricing Analysis
15.11.2. Market Share Analysis, 2022
15.11.2.1. By Type
15.11.2.2. By Treatment Type
15.12. Czech Republic
15.12.1. Pricing Analysis
15.12.2. Market Share Analysis, 2022
15.12.2.1. By Type
15.12.2.2. By Treatment Type
15.13. Romania
15.13.1. Pricing Analysis
15.13.2. Market Share Analysis, 2022
15.13.2.1. By Type
15.13.2.2. By Treatment Type
15.14. India
15.14.1. Pricing Analysis
15.14.2. Market Share Analysis, 2022
15.14.2.1. By Type
15.14.2.2. By Treatment Type
15.15. Bangladesh
15.15.1. Pricing Analysis
15.15.2. Market Share Analysis, 2022
15.15.2.1. By Type
15.15.2.2. By Treatment Type
15.16. Australia
15.16.1. Pricing Analysis
15.16.2. Market Share Analysis, 2022
15.16.2.1. By Type
15.16.2.2. By Treatment Type
15.17. New Zealand
15.17.1. Pricing Analysis
15.17.2. Market Share Analysis, 2022
15.17.2.1. By Type
15.17.2.2. By Treatment Type
15.18. China
15.18.1. Pricing Analysis
15.18.2. Market Share Analysis, 2022
15.18.2.1. By Type
15.18.2.2. By Treatment Type
15.19. Japan
15.19.1. Pricing Analysis
15.19.2. Market Share Analysis, 2022
15.19.2.1. By Type
15.19.2.2. By Treatment Type
15.20. South Korea
15.20.1. Pricing Analysis
15.20.2. Market Share Analysis, 2022
15.20.2.1. By Type
15.20.2.2. By Treatment Type
15.21. GCC Countries
15.21.1. Pricing Analysis
15.21.2. Market Share Analysis, 2022
15.21.2.1. By Type
15.21.2.2. By Treatment Type
15.22. South Africa
15.22.1. Pricing Analysis
15.22.2. Market Share Analysis, 2022
15.22.2.1. By Type
15.22.2.2. By Treatment Type
15.23. Israel
15.23.1. Pricing Analysis
15.23.2. Market Share Analysis, 2022
15.23.2.1. By Type
15.23.2.2. By Treatment Type
16. Market Structure Analysis
16.1. Competition Dashboard
16.2. Competition Benchmarking
16.3. Market Share Analysis of Top Players
16.3.1. By Regional
16.3.2. By Type
16.3.3. By Treatment Type
17. Competition Analysis
17.1. Competition Deep Dive
17.1.1. Becton Dickinson & Company
17.1.1.1. Overview
17.1.1.2. Product Portfolio
17.1.1.3. Profitability by Market Segments
17.1.1.4. Sales Footprint
17.1.1.5. Strategy Overview
17.1.1.5.1. Marketing Strategy
17.1.2. Medtronic
17.1.2.1. Overview
17.1.2.2. Product Portfolio
17.1.2.3. Profitability by Market Segments
17.1.2.4. Sales Footprint
17.1.2.5. Strategy Overview
17.1.2.5.1. Marketing Strategy
17.1.3. B. Braun Melsungen Ag
17.1.3.1. Overview
17.1.3.2. Product Portfolio
17.1.3.3. Profitability by Market Segments
17.1.3.4. Sales Footprint
17.1.3.5. Strategy Overview
17.1.3.5.1. Marketing Strategy
17.1.4. Cook Medical
17.1.4.1. Overview
17.1.4.2. Product Portfolio
17.1.4.3. Profitability by Market Segments
17.1.4.4. Sales Footprint
17.1.4.5. Strategy Overview
17.1.4.5.1. Marketing Strategy
17.1.5. Teleflex Incorporated
17.1.5.1. Overview
17.1.5.2. Product Portfolio
17.1.5.3. Profitability by Market Segments
17.1.5.4. Sales Footprint
17.1.5.5. Strategy Overview
17.1.5.5.1. Marketing Strategy
17.1.6. Fresenius Medical Care AG & Co. KGaA
17.1.6.1. Overview
17.1.6.2. Product Portfolio
17.1.6.3. Profitability by Market Segments
17.1.6.4. Sales Footprint
17.1.6.5. Strategy Overview
17.1.6.5.1. Marketing Strategy
17.1.7. NxStage Medical Inc.
17.1.7.1. Overview
17.1.7.2. Product Portfolio
17.1.7.3. Profitability by Market Segments
17.1.7.4. Sales Footprint
17.1.7.5. Strategy Overview
17.1.7.5.1. Marketing Strategy
17.1.8. Poly Medicure Limited.
17.1.8.1. Overview
17.1.8.2. Product Portfolio
17.1.8.3. Profitability by Market Segments
17.1.8.4. Sales Footprint
17.1.8.5. Strategy Overview
17.1.8.5.1. Marketing Strategy
17.1.9. Shire plc
17.1.9.1. Overview
17.1.9.2. Product Portfolio
17.1.9.3. Profitability by Market Segments
17.1.9.4. Sales Footprint
17.1.9.5. Strategy Overview
17.1.9.5.1. Marketing Strategy
17.1.10. Mayo Clinic
17.1.10.1. Overview
17.1.10.2. Product Portfolio
17.1.10.3. Profitability by Market Segments
17.1.10.4. Sales Footprint
17.1.10.5. Strategy Overview
17.1.10.5.1. Marketing Strategy
17.1.11. Proteon Therapeutics
17.1.11.1. Overview
17.1.11.2. Product Portfolio
17.1.11.3. Profitability by Market Segments
17.1.11.4. Sales Footprint
17.1.11.5. Strategy Overview
17.1.11.5.1. Marketing Strategy
18. Assumptions & Acronyms Used19. Research Methodology
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
List of Tables
Table 1: Global Market Value (US$ Million) Forecast by Region, 2018 to 2033
Table 2: Global Market Value (US$ Million) Forecast by Type, 2018 to 2033
Table 3: Global Market Value (US$ Million) Forecast by Treatment Type, 2018 to 2033
Table 4: North America Market Value (US$ Million) Forecast by Country, 2018 to 2033
Table 5: North America Market Value (US$ Million) Forecast by Type, 2018 to 2033
Table 6: North America Market Value (US$ Million) Forecast by Treatment Type, 2018 to 2033
Table 7: Latin America Market Value (US$ Million) Forecast by Country, 2018 to 2033
Table 8: Latin America Market Value (US$ Million) Forecast by Type, 2018 to 2033
Table 9: Latin America Market Value (US$ Million) Forecast by Treatment Type, 2018 to 2033
Table 10: Western Europe Market Value (US$ Million) Forecast by Country, 2018 to 2033
Table 11: Western Europe Market Value (US$ Million) Forecast by Type, 2018 to 2033
Table 12: Western Europe Market Value (US$ Million) Forecast by Treatment Type, 2018 to 2033
Table 13: Eastern Europe Market Value (US$ Million) Forecast by Country, 2018 to 2033
Table 14: Eastern Europe Market Value (US$ Million) Forecast by Type, 2018 to 2033
Table 15: Eastern Europe Market Value (US$ Million) Forecast by Treatment Type, 2018 to 2033
Table 16: South Asia and Pacific Market Value (US$ Million) Forecast by Country, 2018 to 2033
Table 17: South Asia and Pacific Market Value (US$ Million) Forecast by Type, 2018 to 2033
Table 18: South Asia and Pacific Market Value (US$ Million) Forecast by Treatment Type, 2018 to 2033
Table 19: East Asia Market Value (US$ Million) Forecast by Country, 2018 to 2033
Table 20: East Asia Market Value (US$ Million) Forecast by Type, 2018 to 2033
Table 21: East Asia Market Value (US$ Million) Forecast by Treatment Type, 2018 to 2033
Table 22: Middle East and Africa Market Value (US$ Million) Forecast by Country, 2018 to 2033
Table 23: Middle East and Africa Market Value (US$ Million) Forecast by Type, 2018 to 2033
Table 24: Middle East and Africa Market Value (US$ Million) Forecast by Treatment Type, 2018 to 2033
Find your sweet spots for generating winning opportunities in this market.
List of Charts
Figure 1: Global Market Value (US$ Million) by Type, 2023 to 2033
Figure 2: Global Market Value (US$ Million) by Treatment Type, 2023 to 2033
Figure 3: Global Market Value (US$ Million) by Region, 2023 to 2033
Figure 4: Global Market Value (US$ Million) Analysis by Region, 2018 to 2033
Figure 5: Global Market Value Share (%) and BPS Analysis by Region, 2023 to 2033
Figure 6: Global Market Y-o-Y Growth (%) Projections by Region, 2023 to 2033
Figure 7: Global Market Value (US$ Million) Analysis by Type, 2018 to 2033
Figure 8: Global Market Value Share (%) and BPS Analysis by Type, 2023 to 2033
Figure 9: Global Market Y-o-Y Growth (%) Projections by Type, 2023 to 2033
Figure 10: Global Market Value (US$ Million) Analysis by Treatment Type, 2018 to 2033
Figure 11: Global Market Value Share (%) and BPS Analysis by Treatment Type, 2023 to 2033
Figure 12: Global Market Y-o-Y Growth (%) Projections by Treatment Type, 2023 to 2033
Figure 13: Global Market Attractiveness by Type, 2023 to 2033
Figure 14: Global Market Attractiveness by Treatment Type, 2023 to 2033
Figure 15: Global Market Attractiveness by Region, 2023 to 2033
Figure 16: North America Market Value (US$ Million) by Type, 2023 to 2033
Figure 17: North America Market Value (US$ Million) by Treatment Type, 2023 to 2033
Figure 18: North America Market Value (US$ Million) by Country, 2023 to 2033
Figure 19: North America Market Value (US$ Million) Analysis by Country, 2018 to 2033
Figure 20: North America Market Value Share (%) and BPS Analysis by Country, 2023 to 2033
Figure 21: North America Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033
Figure 22: North America Market Value (US$ Million) Analysis by Type, 2018 to 2033
Figure 23: North America Market Value Share (%) and BPS Analysis by Type, 2023 to 2033
Figure 24: North America Market Y-o-Y Growth (%) Projections by Type, 2023 to 2033
Figure 25: North America Market Value (US$ Million) Analysis by Treatment Type, 2018 to 2033
Figure 26: North America Market Value Share (%) and BPS Analysis by Treatment Type, 2023 to 2033
Figure 27: North America Market Y-o-Y Growth (%) Projections by Treatment Type, 2023 to 2033
Figure 28: North America Market Attractiveness by Type, 2023 to 2033
Figure 29: North America Market Attractiveness by Treatment Type, 2023 to 2033
Figure 30: North America Market Attractiveness by Country, 2023 to 2033
Figure 31: Latin America Market Value (US$ Million) by Type, 2023 to 2033
Figure 32: Latin America Market Value (US$ Million) by Treatment Type, 2023 to 2033
Figure 33: Latin America Market Value (US$ Million) by Country, 2023 to 2033
Figure 34: Latin America Market Value (US$ Million) Analysis by Country, 2018 to 2033
Figure 35: Latin America Market Value Share (%) and BPS Analysis by Country, 2023 to 2033
Figure 36: Latin America Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033
Figure 37: Latin America Market Value (US$ Million) Analysis by Type, 2018 to 2033
Figure 38: Latin America Market Value Share (%) and BPS Analysis by Type, 2023 to 2033
Figure 39: Latin America Market Y-o-Y Growth (%) Projections by Type, 2023 to 2033
Figure 40: Latin America Market Value (US$ Million) Analysis by Treatment Type, 2018 to 2033
Figure 41: Latin America Market Value Share (%) and BPS Analysis by Treatment Type, 2023 to 2033
Figure 42: Latin America Market Y-o-Y Growth (%) Projections by Treatment Type, 2023 to 2033
Figure 43: Latin America Market Attractiveness by Type, 2023 to 2033
Figure 44: Latin America Market Attractiveness by Treatment Type, 2023 to 2033
Figure 45: Latin America Market Attractiveness by Country, 2023 to 2033
Figure 46: Western Europe Market Value (US$ Million) by Type, 2023 to 2033
Figure 47: Western Europe Market Value (US$ Million) by Treatment Type, 2023 to 2033
Figure 48: Western Europe Market Value (US$ Million) by Country, 2023 to 2033
Figure 49: Western Europe Market Value (US$ Million) Analysis by Country, 2018 to 2033
Figure 50: Western Europe Market Value Share (%) and BPS Analysis by Country, 2023 to 2033
Figure 51: Western Europe Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033
Figure 52: Western Europe Market Value (US$ Million) Analysis by Type, 2018 to 2033
Figure 53: Western Europe Market Value Share (%) and BPS Analysis by Type, 2023 to 2033
Figure 54: Western Europe Market Y-o-Y Growth (%) Projections by Type, 2023 to 2033
Figure 55: Western Europe Market Value (US$ Million) Analysis by Treatment Type, 2018 to 2033
Figure 56: Western Europe Market Value Share (%) and BPS Analysis by Treatment Type, 2023 to 2033
Figure 57: Western Europe Market Y-o-Y Growth (%) Projections by Treatment Type, 2023 to 2033
Figure 58: Western Europe Market Attractiveness by Type, 2023 to 2033
Figure 59: Western Europe Market Attractiveness by Treatment Type, 2023 to 2033
Figure 60: Western Europe Market Attractiveness by Country, 2023 to 2033
Figure 61: Eastern Europe Market Value (US$ Million) by Type, 2023 to 2033
Figure 62: Eastern Europe Market Value (US$ Million) by Treatment Type, 2023 to 2033
Figure 63: Eastern Europe Market Value (US$ Million) by Country, 2023 to 2033
Figure 64: Eastern Europe Market Value (US$ Million) Analysis by Country, 2018 to 2033
Figure 65: Eastern Europe Market Value Share (%) and BPS Analysis by Country, 2023 to 2033
Figure 66: Eastern Europe Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033
Figure 67: Eastern Europe Market Value (US$ Million) Analysis by Type, 2018 to 2033
Figure 68: Eastern Europe Market Value Share (%) and BPS Analysis by Type, 2023 to 2033
Figure 69: Eastern Europe Market Y-o-Y Growth (%) Projections by Type, 2023 to 2033
Figure 70: Eastern Europe Market Value (US$ Million) Analysis by Treatment Type, 2018 to 2033
Figure 71: Eastern Europe Market Value Share (%) and BPS Analysis by Treatment Type, 2023 to 2033
Figure 72: Eastern Europe Market Y-o-Y Growth (%) Projections by Treatment Type, 2023 to 2033
Figure 73: Eastern Europe Market Attractiveness by Type, 2023 to 2033
Figure 74: Eastern Europe Market Attractiveness by Treatment Type, 2023 to 2033
Figure 75: Eastern Europe Market Attractiveness by Country, 2023 to 2033
Figure 76: South Asia and Pacific Market Value (US$ Million) by Type, 2023 to 2033
Figure 77: South Asia and Pacific Market Value (US$ Million) by Treatment Type, 2023 to 2033
Figure 78: South Asia and Pacific Market Value (US$ Million) by Country, 2023 to 2033
Figure 79: South Asia and Pacific Market Value (US$ Million) Analysis by Country, 2018 to 2033
Figure 80: South Asia and Pacific Market Value Share (%) and BPS Analysis by Country, 2023 to 2033
Figure 81: South Asia and Pacific Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033
Figure 82: South Asia and Pacific Market Value (US$ Million) Analysis by Type, 2018 to 2033
Figure 83: South Asia and Pacific Market Value Share (%) and BPS Analysis by Type, 2023 to 2033
Figure 84: South Asia and Pacific Market Y-o-Y Growth (%) Projections by Type, 2023 to 2033
Figure 85: South Asia and Pacific Market Value (US$ Million) Analysis by Treatment Type, 2018 to 2033
Figure 86: South Asia and Pacific Market Value Share (%) and BPS Analysis by Treatment Type, 2023 to 2033
Figure 87: South Asia and Pacific Market Y-o-Y Growth (%) Projections by Treatment Type, 2023 to 2033
Figure 88: South Asia and Pacific Market Attractiveness by Type, 2023 to 2033
Figure 89: South Asia and Pacific Market Attractiveness by Treatment Type, 2023 to 2033
Figure 90: South Asia and Pacific Market Attractiveness by Country, 2023 to 2033
Figure 91: East Asia Market Value (US$ Million) by Type, 2023 to 2033
Figure 92: East Asia Market Value (US$ Million) by Treatment Type, 2023 to 2033
Figure 93: East Asia Market Value (US$ Million) by Country, 2023 to 2033
Figure 94: East Asia Market Value (US$ Million) Analysis by Country, 2018 to 2033
Figure 95: East Asia Market Value Share (%) and BPS Analysis by Country, 2023 to 2033
Figure 96: East Asia Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033
Figure 97: East Asia Market Value (US$ Million) Analysis by Type, 2018 to 2033
Figure 98: East Asia Market Value Share (%) and BPS Analysis by Type, 2023 to 2033
Figure 99: East Asia Market Y-o-Y Growth (%) Projections by Type, 2023 to 2033
Figure 100: East Asia Market Value (US$ Million) Analysis by Treatment Type, 2018 to 2033
Figure 101: East Asia Market Value Share (%) and BPS Analysis by Treatment Type, 2023 to 2033
Figure 102: East Asia Market Y-o-Y Growth (%) Projections by Treatment Type, 2023 to 2033
Figure 103: East Asia Market Attractiveness by Type, 2023 to 2033
Figure 104: East Asia Market Attractiveness by Treatment Type, 2023 to 2033
Figure 105: East Asia Market Attractiveness by Country, 2023 to 2033
Figure 106: Middle East and Africa Market Value (US$ Million) by Type, 2023 to 2033
Figure 107: Middle East and Africa Market Value (US$ Million) by Treatment Type, 2023 to 2033
Figure 108: Middle East and Africa Market Value (US$ Million) by Country, 2023 to 2033
Figure 109: Middle East and Africa Market Value (US$ Million) Analysis by Country, 2018 to 2033
Figure 110: Middle East and Africa Market Value Share (%) and BPS Analysis by Country, 2023 to 2033
Figure 111: Middle East and Africa Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033
Figure 112: Middle East and Africa Market Value (US$ Million) Analysis by Type, 2018 to 2033
Figure 113: Middle East and Africa Market Value Share (%) and BPS Analysis by Type, 2023 to 2033
Figure 114: Middle East and Africa Market Y-o-Y Growth (%) Projections by Type, 2023 to 2033
Figure 115: Middle East and Africa Market Value (US$ Million) Analysis by Treatment Type, 2018 to 2033
Figure 116: Middle East and Africa Market Value Share (%) and BPS Analysis by Treatment Type, 2023 to 2033
Figure 117: Middle East and Africa Market Y-o-Y Growth (%) Projections by Treatment Type, 2023 to 2033
Figure 118: Middle East and Africa Market Attractiveness by Type, 2023 to 2033
Figure 119: Middle East and Africa Market Attractiveness by Treatment Type, 2023 to 2033
Figure 120: Middle East and Africa Market Attractiveness by Country, 2023 to 2033
